Barely Significant
← all excerpts

Curcumin Supplementation and Human Disease: A Scoping Review of Clinical Trials.

Int J Mol Sci · 2023 · PMC10003109 · PMID 36901908

1
hedged sentence
closest p
boldest claim

The sentences

an encouraging trendno p-value reported
The systematic review reported a 48% compliance rate for all parameters in curcumin trials assessed, which increased to 67% in recent years, an encouraging trend consistent with general findings reported here, where many—but not all—studies utilized optimal designs.

also in 160 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.